GLP-1 analogs , particularly those like BrightMeds, are rapidly gaining prominence in the management of type 2 diabetes and are also explored for metabolic conditions. These novel drugs work by mimicking the https://brightmeds365556.bloggazza.com/41542683/brightmeds-glp-1-a-deep-investigation-into-this-emerging-therapy